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Abstract
Background: Previous studies have identified that variants in peroxisome proliferator-activated receptor PPAR-d (PPARD), a
target gene of vitamin D, were significantly associated with fasting glucose and insulin sensitivity in European populations.
This current study sought to determine (1) whether the genetic associations of PPARD variants with type 2 diabetes and its
related traits could be replicated in Chinese Han population, and (2) whether the associations would be modified by the
effect of vitamin D status.
Methods and Findings: We genotyped 9 tag single nucleotide polymorphisms (SNPs) that cover the gene of PPARD
(rs2267664, rs6902123, rs3798343, rs2267665, rs2267668, rs2016520, rs2299869, rs1053049, and rs9658056) and tested their
associations with type 2 diabetes risk and its related traits, including fasting glucose, insulin and HbA1c in 3,210 Chinese
Hans. Among the 9 PPARD tag SNPs, rs6902123 was significantly associated with risk of type 2 diabetes (odds ratio 1.75
[95%CI 1.22–2.53]; P=0.0025) and combined type 2 diabetes and impaired fasting glucose (IFG) (odds ratio 1.47 [95%CI
1.12–1.92]; P=0.0054). The minor C allele of rs6902123 was associated with increased levels of fasting glucose (P=0.0316)
and HbA1c (P=0.0180). In addition, we observed that vitamin D modified the effect of rs6902123 on HbA1c (P for
interaction=0.0347).
Conclusions/Significance: Our findings demonstrate that common variants in PPARD contribute to the risk of type 2
diabetes in Chinese Hans, and provided suggestive evidence of interaction between 25(OH)D levels and PPARD-rs6902123
on HbA1c.
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Introduction
Peroxisome proliferator-activated receptor (PPAR)-d, a member
of PPAR family, is widely expressed in a variety of tissues, and
regulated by several environmental factors like vitamin D [1] and
physical activity [2], which are influencing factors for type 2
diabetes [3,4]. Evidence from in vitro study indicated that PPAR-d-
specific agonist promoted glucose uptake in cultured primary
human skeletal myotubes [5]. Animal studies found that PPAR-d
knockout mice showed glucose intolerance on normal chow [6],
and were prone to obesity on high-fat diet [7]. Meanwhile,
treatment with PPAR-d-specific agonist (GW501516) could
enhanced b-oxidation, decreased free fatty acid, and improved
insulin sensitivity in db/db mice [6] and moderately obese men [8].
Hence, PPAR-d is recognized as a target for treatment of
metabolic syndromes and type 2 diabetes [9,10].
The effects of PPARD variants on type 2 diabetes and the
metabolic related traits has been widely investigated, however, the
results were inconsistent. Previous candidate gene association
studies in Europeans have reported that common variants in
PPARD were associated with fasting glucose [11], insulin resistance
[11,12], BMI [13], LDL-cholesterol [14], HDL-cholesterol
[13,15],and risk of conversion from impaired glucose tolerance
(IGT) to type 2 diabetes [16]. In Asian population, only two case-
control studies were conducted in Korea [17] and China [18],
which found that variants in PPARD (rs2016520, rs9658173,
rs1053049 and c.2806 C.G) were associated with fasting glucose
and/or BMI in Korean [17], and the C allele of rs2016520 was
associated with higher fasting glucose and lower insulin sensitivity
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34895in Chinese [18]. These findings suggested a contribution of PPARD
to the risk of type 2 diabetes and related metabolic traits.
It is well-established that type 2 diabetes is a common complex
disease influenced by both genetic factors and environmental
factors [19]. In order to completely understand the role of PPARD
in etiology of type 2 diabetes, investigation on the interactions
between environmental factors and common genetic variants in
PPARD is required. Vitamin D, which was associated with glucose
homeostasis in our previous study [20], was shown to be a
regulator of PPARD expression [1], and the vitamin D receptor
response elements was found in the promoter of PPARD [1].
Hence, Vitamin D status might influence the effect of variants in
PPARD on risk of type 2 diabetes and related traits. Despite of the
important role of vitamin D in glucose homeostasis [4,20],
previous studies did not assess the potential gene-nutrients
interaction between the variants in PPARD and vitamin D status.
Therefore, the primary aim of this study is to investigate the
effect of PPARD SNPs on the risk of having type 2 diabetes and its
related phenotype in a relative large population-based Han
Chinese sample. Given the regulative effect of vitamin D on
PPAR-d expression [1], we also sought to examine the potential
modifying effects of plasma 25-hydoxyvitamin D (25[OH]D)
levels, the indicator of vitamin D status, on the associations
between PPARD common variants and type 2 diabetes as well as its
related traits.
Materials and Methods
Study Population
The present study consisted of 3210 unrelated Chinese Hans
(1423 men and 1787 women) aged 50–70 years from Beijing and
Shanghai, which is part of the Nutrition and Health of Aging
Population in China (NHAPC) projects, a population-based
cohort. The details of the study design and protocols have been
described previously [21]. In brief, in a home interview,
information about age, sex, geographical region (Beijing/Shang-
hai), health status, medication use and physical activity was
collected by a standardized questionnaire. After the home
interview, all participants attended a clinical examination,
including anthropometric measurements and overnight blood
sample collection. Height, weight, blood pressure, fasting glucose,
insulin, HbA1c and 25(OH)D were measured following standard
protocols which were described previously [20,21]. BMI was
calculated as weight in kilograms divided by the square of height in
meters. Homeostasis model assessment of insulin resistance
(HOMA-R) and of beta cell function (HOMA-B) was estimated
using updated homeostasis model assessment methods [22]. The
study was approved by the institutional review board of the
Institute for Nutritional Sciences, and all participants provided
informed consent. The phenotypic characteristics of the popula-
tion are shown in Table 1.
Definition of Type 2 diabetes
Type 2 diabetes was defined by either 1999 World Health
Organization criteria [23] or previously diagnosed type 2 diabetes.
Normal fasting glucose (NFG) and impaired fasting glucose (IFG)
were defined as fasting glucose ,5.6 mmol/l (100 mg/dl) and
5.6 mmol/l to 7.0 mmol/l (126 mg/dl), respectively. Among the
participants, 424 had type 2 diabetes (267 previously diagnosed,
157 screen-detected and treatment-naı ¨ve), 878 had impaired
fasting glucose (IFG) (all screen-detected and treatment-naive), and
1908 had normal fasting glucose (NFG).
Genotyping
DNA extraction from peripheral blood leucocytes was per-
formed by a salting out procedure (http://www.protocol-online.
org/prot/Detailed/3171.html, accessed 1 January 2009). Haplo-
view software (available at http://www.broadinstitute.org/
haploview/haploview) were applied to select the nine PPARD
variants (rs2267664, rs6902123, rs3798343, rs2267665,
rs2267668, rs2016520, rs2299869, rs1053049 and rs9658056),
which captured all SNPs with minor allele frequencies
(MAFs)$0.05 based on HapMap-CHB database (Rel24/phase
II Nov08) in the gene of PPARD and 5 kb of its upstream and
downstream regions (Table S1). These nine SNPs were genotyped
using the GenomeLab SNPstream system (Beckman Coulter,
Fullerton, CA, USA). The genotyping success rate was .96%, and
the concordance rate was .99% based on 12% duplicated
samples (n=384). All the nine SNPs genotyped in our study were
in Hardy-Weinberg equilibrium (P.0.01). The SNP rs9658056
was not included in statistical analyses due to its very low
frequency (MAF=0.003) in our samples. Genotypic distributions
were similar in Beijing and Shanghai subpopulations (P.0.05),
except rs3798343, rs2299869 and rs2267664 (P=0.0001, 0.0221
and ,0.0001 for rs3798343, rs2299869 and rs2267664, respec-
tively).
Statistical analyses
Insulin and HOMA-R were log-transformed to approach
normal distributions. Due to the differences of phenotypic
characteristics between individuals from Beijing and Shanghai,
association analyses for all SNPs were performed in individuals
from Beijing and Shanghai separately. Subsequently, we applied
fixed-effect meta-analysis to combine the summary statistics of the
associations from the two subpopulations. A logistic regression
model was used to evaluate the association of each SNP with type
2 diabetes and combined IFG/type 2 diabetes under the additive
or dominant models (if counts of minor allele homozygote ,10).
For quantitative traits analyses, participants with known diabetes
or receiving glucose-lowering treatment (n=267) were excluded.
Generalized linear regression was applied to quantitative traits
analyses under additive or dominant model. The potential
Table 1. Characteristics of study population.
Characteristics All Beijing Shanghai
n 3210 1574 1636
Male (%) 1423 (44.3) 711 (45.2) 712 (43.5)
Age (years) 58.666.0 58.365.9 58.966.0
BMI (kg/m
2) 24.463.6 25.263.7 23.663.3
Fasting glucose
(mmol/l)
5.8461.74 6.1661.96 5.5361.42
HbA1c (%) 5.9961.10 6.0861.22 5.9060.96
Fasting insulin
(pmol/l)
82.2
(59.4–112.2)
80.7
(57.6–110.4)
84.0
(61.8–114.0)
HOMA-B (%) 110.3647.0 100.1644.9 120.0646.9
HOMA-IR 1.57 (1.15–2.12) 1.56 (1.12–2.11) 1.57 (1.18–2.13)
IFG (%) 878 (27.4) 579 (36.8) 299 (18.3)
Type 2 diabetes (%) 424 (13.2) 272 (17.3) 152 (9.3)
25(OH)D (nmol/L) 41.0 (31.3–54.3) 35.8 (27.5–45.9) 47.6 (36.6–60.4)
Unless otherwise indicated, data are means 6 SD, median (interquartile range)
or n (%).
doi:10.1371/journal.pone.0034895.t001
Variants in PPARD, Vitamin D and Type 2 Diabetes
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e34895modifying effects of 25(OH)D levels on genetic associations with
type 2 diabetes or its related traits were evaluated by introducing a
gene x nutrient interactive term into the logistic or linear
regression models. All association analyses were adjusted for age,
sex, and BMI. Quanto program (http://hydra.usc.edu/gxe/) was
used for power calculation. All reported P values are nominal and
two-sided. The statistical analyses were performed using SAS
version 9.1 (SAS Institute, Cary, NC, USA).
Results
All effect-allele frequencies observed in this study were
comparable to those in HapMap-CHB sample. Three of the eight
SNPs (rs2299869, rs2267664 and rs3798343) have higher effect-
allele frequencies in Chinese Hans than those in HapMap-CEU
population, while allele-frequencies were similar for the remaining
five SNPs (Table 2 and Table S2). Linkage disequilibrium (LD)
pattern among these SNPs was shown in Figure S1.
We investigated the associations of variants in PPARD with the
risks of type 2 diabetes in a Chinese Han population by case-
control analyses. Among the eight variants we studied, the SNP
rs6902123 showed significant association with type 2 diabetes (OR
1.75, 95%CI [1.22–2.53], P=0.0025) and combined IFG/type 2
diabetes (OR 1.47, 95%CI [1.12–1.92], P=0.0054) under a
dominant model (Table 2). The associations remained significant
after Bonferroni corrections (P,0.0063, 0.05/8 tests). However,
no further association with type 2 diabetes or combined IFG/type
2 diabetes were detected for the rest PPARD variants in our study
(Table S2).
In quantitative traits analyses, we identified that the minor allele
of rs6902123 was significantly associated with higher levels of
fasting glucose (P=0.0316) and HbA1c (P=0.0180) (Table 3). No
evidence of associations with other PPARD SNPs was observed in
this Chinese Han population (Table S3). In addition, no significant
association was observed after Bonferroni correction.
Next, an exploratory study was conducted to assess the
interactive effects of PPARD-rs6902123 and 25(OH)D levels on
type 2 diabetes, combined IFG/type 2 diabetes, and their related
traits. However, potential interaction was only detected between
rs6902123 and quartiles of 25(OH)D for HbA1c levels (P for
interaction=0.0347), but not for other phenotypes in Chinese
Hans (Figure 1). In stratified analysis, the C allele carriers of
rs6902123 were only found to have significantly increased HbA1c
than the TT genotype carriers in the lowest quartile of 25(OH)D
(P=0.0172), suggesting that increasing 25(OH)D would attenuat-
ed the risk effect of C allele of rs6902123 on HbA1c level.
Discussion
In this study of Chinese Han population, we systematically
investigated the SNPs in PPARD by a gene-wide tagging approach,
instead of testing only a few SNPs. The PPARD-rs6902123 C allele
exhibited significant associations with increased risk of type 2
diabetes, combined IFG/type 2 diabetes, higher fasting glucose
and HbA1c. Further analyses suggested an interaction between
rs6902123 and 25(OH)D on HbA1c.
Previous studies provided controversial results on associations
between PPARD-rs6902123 and type 2 diabetes and its related
traits. In the STOP-NIDDM Trial, 2.47-fold increased risk of
conversion from impaired glucose tolerance to type 2 diabetes was
observed in female carriers of the rs6902123 C allele [16], which
was in line with our results. However, one study in white
population reported that common variants in PPARD, including
rs6902123, did not significantly affect the risk of metabolic disease,
except that a modest significant association was observed between
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increased fasting glucose [11]. This discrepancy may be due to the
different LD pattern between Chinese Hans and European. The
variant rs6902123 is in complete linkage disequilibrium (LD r
2=1)
with SNPs of rs947001 and rs6457816 in Chinese Hans, but
modestly correlated with the two SNPs in Europeans (LD r
2=0.54
and 0.89 for rs947001 and rs6457816, respectively). Since there is
no prior evidence of the potential functional role of the associated
variant rs6902123, whether it is a causal variant or is in LD with
the causal variant need to be determined in further studies using
fine-mapping or re-sequencing strategies, as well as the functional
assays.
The underlying mechanisms responsible for the association
between PPARD-rs6902123 and type 2 diabetes remain to be
elucidated. PPARD knock out mice are glucose intolerant, whereas
treatment of db/db mice with PPAR-d-specific agonist decreased
hepatic glucose production, increased insulin stimulated-glucose
disposal rate, lower free fatty acid levels, and subsequently
improved insulin sensitivity [6]. Nevertheless, we failed to provide
evidence for associations between PPARD-rs6902123 and HOMA-
R. Absence of this association in our study might partially be
attributable to insufficient power, since we only have 40% power
to detect a beta value of 0.05 for log-transformed HOMA-R at
P,0.05. Moreover, evidence from in vitro study indicated PPAR-d-
specific agonist promoted glucose uptake in cultured primary
human skeletal myotubes by increasing AMPK expression and
phosphorylation in the absence of insulin, suggesting PPAR-d-
specific agonist directly improved glucose uptake through an
insulin-independent mechanism and enhanced subsequent insulin
stimulation [5].
For PPARD-rs2016520 variant, we only found a marginal
association with combined IFG/type 2 diabetes, but not with the
risk of type 2 diabetes and related traits. In line with our results,
rs2016520 was also not associated with the risk of type 2 diabetes
in a Chinese case-control study, in which the subjects were
recruited from the out-patient clinic [18]. However, they found
that rs2016520 C allele was associated with higher fasting glucose
and impaired insulin sensitivity in both normal glucose tolerant
and diabetic subjects [18]. This discrepancy may be due to the
different sampling method and population structure between the
two studies. Our study was a population-based study among non-
institutionalized Chinese people in Beijing and Shanghai. This
design has the advantage of allowing estimation of the genetic
effect at the population level among Chinese Han middle-aged
people. In addition, the possibility of false-negative results caused
by insufficient power could not be completely excluded. Assuming
an additive model and a minor allele frequency of 26%, we had
less than 50% power to detect the previously reported beta value
for fasting glucose at P,0.05 [18]. Meta-analysis or studies with
larger sample sizes will be required to draw definitive conclusions.
No evidence of associations with other PPARD SNPs was
observed in this Chinese Han population. This is very likely
attributable to the weak linkage disequilibrium between these
variants and the causal variants. However, we could not rule out
the possibility of insufficient power. Assuming an additive model
and a minor allele frequency of 20%, we had 43% and 79% power
to detect the effect of a SNP with odds ratio 1.3 at P,0.05 for risk
of type 2 diabetes and combined IFG/type 2 diabetes, respective-
ly, in Shanghai subpopulation, and 56% and 85% power for risk of
type 2 diabetes and combined IFG/type 2 diabetes, respectively,
in Beijing subpopulation. In addition, we only have 59% and 60%
Table 3. Associations with type 2 diabetes related quantitative traits in 2,943 Chinese Hans.
SNP ID Glucose (mmol/L)
a HbA1c (%)
a Insulin (mmol/L)
ab HOMA-B (%)
a HOMA-IR (%)
ab
b (SE) P b (SE) P b (SE) P b (SE) P b (SE) P
rs6902123
c
Beijing 0.301 (0.138) 0.0296 0.241 (0.090) 0.0073 0.002 (0.049) 0.9740 25.883 (4.018) 0.1433 20.015 (0.046) 0.7416
Shanghai 0.107 (0.099) 0.2773 0.064 (0.067) 0.3362 0.030 (0.046) 0.5128 0.218 (4.318) 0.9598 0.032 (0.045) 0.4802
Combined
d 0.173 (0.080) 0.0316 0.127 (0.054) 0.0180 0.017 (0.034) 0.6147 23.050 (2.940) 0.2995 0.009 (0.032) 0.7793
P for
heterogeneity
0.2533 0.1147 0.6770 0.301 0.4652
aThe P values were adjusted for age, sex and BMI.
bLog-transformed before analyses.
cDominant model was applied.
dFixed-effect model was used in the meta-analysis.
doi:10.1371/journal.pone.0034895.t003
Figure 1. Interaction between PPARD-rs6902123 and plasma
25-hydroxyvitamin D levels on HbA1c. The means (SE) of HbA1c
by PPARD-rs6902123 genotypes according to quartiles of plasma 25-
hydroxyvitamin D concentrations were calculated in 2943 subjects, with
adjustment for age, sex, geographic region (Beijing and Shanghai) and
BMI (P for interaction=0.0347). Participants with known diabetes or
using glucose-lowering treatment were excluded. C allele carriers
(black) had significant higher HbA1c concentrations than TT carriers
(gray) (P=0.0172) in the lowest group of 25-hydroxyvitamin D, but not
in the other groups (P$0.0814).
doi:10.1371/journal.pone.0034895.g001
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quantitative traits in Beijing and Shanghai subpopulation,
respectively. Thus, further larger studies are warranted.
Given the regulative effect of vitamin D on the expression of
PPARD [1], we also assessed the interaction between PPARD-
rs6902123 and 25(OH)D levels, the accepted indicator of vitamin
D status. We found a significant modifying effect of 25(OH)D
levels on the association of PPARD-rs6902123 with HbA1c. The
PPARD-rs6902123 C allele was significantly associated with higher
HbA1c level only in the lowest group of 25(OH)D levels. The
mechanism underlying this interaction between 25(OH)D levels
and rs6902123 is unclear. Vitamin D is a steroid, which play an
important role in insulin secretion and glucose uptake through
directly modulating gene expression via vitamin D receptors
(VDRs) as well as through regulating calcium flux [24]. In our
previous study, we found that 25(OH)D, generally accepted
indicator of vitamin D status, was associated with fasting glucose,
HbA1c and insulin resistance in Chinese middle-aged population
[20]. In addition, a VDR response element was found in the
promoter of PPARD [1]. Therefore, we assume that the higher
level of vitamin D status may alleviate the negative effect of
PPARD-rs6902123 C allele on HbA1c by regulating the expression
of PPARD. Although, the interaction was no longer significant after
Bonferroni correction, it might result from the relatively smaller
sample size in our study for analysis of gene by environmental
interaction. However, it was so far, the first study to explore the
interaction between vitamin D status and PPARD-rs6902123, and
provided the suggestive evidence of interaction. Given the
epidemic of vitamin D deficiency in the world [25], it is worthy
of conducting more studies with large sample size to draw a
definite conclusion.
In conclusion, we have reported for the first time that PPARD-
rs6902123 C allele was associated with higher fasting glucose,
HbA1c, and increased risk of type 2 diabetes and combined IFG/
type 2 diabetes in a population-based Chinese Han sample.
Moreover, we provided the suggestive evidence of interaction
between 25(OH)D levels and PPARD-rs6902123 on HbA1c,
indicating a possible crosstalk between PPAR-d and vitamin D
pathway.
Supporting Information
Figure S1 Linkage disequilibrium among the eight SNPs in
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